Gut Microbiome Composition in Patients with Liver Cirrhosis with and Without Hepatic Encephalopathy: A Systematic Review and Meta-analysis

Overview

Journal World J Hepatol

Publisher Baishideng Publishing Group

Date 2025 Jan 28

PMID 39871903

Authors

Xiao-Tong Xu

Min-Jie Jiang

Yun-Lai Fu

Fang Xie

Jian-Jun Li

Qing-Hua Meng

Affiliations

Soon will be listed here.

Abstract

Background: The gut microbiome is associated with hepatic encephalopathy (HE), but research results on the gut microbiome characteristics of patients with liver cirrhosis with and without HE are inconsistent.

Aim: To study the gut microbiota characteristics of patients with liver cirrhosis with and without HE.

Methods: We searched the PubMed, Web of Science, EMBASE, and Cochrane databases using two keywords, HE, and gut microbiome. According to the inclusion and exclusion criteria, suitable literature was screened to extract data on the diversity and composition of the fecal microbiota in patients with liver cirrhosis with and without HE. The data were analyzed using RevMan and STATA.

Results: Seventeen studies were included: (1) A meta-analysis of 7 studies revealed that the Shannon index in liver cirrhosis patients with HE was significantly lower than that in patients without HE [-0.20, 95% confidence interval (CI): -0.28 to -0.13, = 20%]; (2) The relative abundances of (-2.73, 95%CI: -4.58 to -0.87, = 38%) and (-2.93, 95%CI: -4.29 to -1.56, = 0%) in liver cirrhosis patients with HE was significantly lower than those in patients without HE; (3) In patients with HE, , , , and proportions increased, but , , , and proportions decreased; (4) Differences in the fecal metabolome between liver cirrhosis patients with and without HE were detected; and (5) Differential gut microbiomes may serve as diagnostic and prognostic tools.

Conclusion: The gut microbiomes of patients with liver cirrhosis with and without HE differ. Some gut microbiomes may distinguish liver cirrhosis patients with or without HE and determine patient prognosis.

References

Zhang J, Zhang C, Zhang Q, Yu L, Chen W, Xue Y . Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota. BMC Microbiol. 2023; 23(1):171. PMC: 10278323. DOI: 10.1186/s12866-023-02895-w. View

Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L . Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014; 513(7516):59-64. DOI: 10.1038/nature13568. View

Chen Y, Guo J, Qian G, Fang D, Shi D, Guo L . Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality. J Gastroenterol Hepatol. 2015; 30(9):1429-37. DOI: 10.1111/jgh.12932. View

Bajaj J, Fagan A, Sikaroodi M, White M, Sterling R, Gilles H . Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. Liver Transpl. 2017; 23(7):907-914. DOI: 10.1002/lt.24754. View

Bajaj J, Torre A, Rojas M, Fagan A, Nandez I, Gavis E . Cognition and hospitalizations are linked with salivary and faecal microbiota in cirrhosis cohorts from the USA and Mexico. Liver Int. 2020; 40(6):1395-1407. DOI: 10.1111/liv.14437. View

Wu Z, Zhou H, Liu D, Deng F . Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis. Front Cell Infect Microbiol. 2023; 13:1218552. PMC: 10361729. DOI: 10.3389/fcimb.2023.1218552. View

Chen Z, Ruan J, Li D, Wang M, Han Z, Qiu W . The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy. Front Cell Infect Microbiol. 2021; 10:595759. PMC: 7859631. DOI: 10.3389/fcimb.2020.595759. View

Kang D, Kakiyama G, Betrapally N, Herzog J, Nittono H, Hylemon P . Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition. Clin Transl Gastroenterol. 2016; 7(8):e187. PMC: 5543406. DOI: 10.1038/ctg.2016.44. View

Elsaid M, Rustgi V . Epidemiology of Hepatic Encephalopathy. Clin Liver Dis. 2020; 24(2):157-174. DOI: 10.1016/j.cld.2020.01.001. View

10.

Bajaj J, Vargas H, Reddy K, Lai J, OLeary J, Tandon P . Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2018; 17(4):756-765.e3. DOI: 10.1016/j.cgh.2018.07.022. View

11.

Minalyan A, Gabrielyan L, Scott D, Jacobs J, Pisegna J . The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors. Curr Gastroenterol Rep. 2017; 19(8):42. PMC: 5621514. DOI: 10.1007/s11894-017-0577-6. View

12.

Bajaj J, Hylemon P, Ridlon J, Heuman D, Daita K, White M . Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol. 2012; 303(6):G675-85. PMC: 3468538. DOI: 10.1152/ajpgi.00152.2012. View

13.

Tsai C, Chen M, Wang Y, Chu C, Huang Y, Lin H . Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. Gastroenterology. 2016; 152(1):134-141. DOI: 10.1053/j.gastro.2016.09.007. View

14.

Won S, Oh K, Gupta H, Ganesan R, Sharma S, Jeong J . The Link between Gut Microbiota and Hepatic Encephalopathy. Int J Mol Sci. 2022; 23(16). PMC: 9408988. DOI: 10.3390/ijms23168999. View

15.

Bajaj J, Heuman D, Sanyal A, Hylemon P, Sterling R, Stravitz R . Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One. 2013; 8(4):e60042. PMC: 3615021. DOI: 10.1371/journal.pone.0060042. View

16.

Li M, Li K, Tang S, Lv Y, Wang Q, Wang Z . Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS. JHEP Rep. 2022; 4(5):100448. PMC: 8933702. DOI: 10.1016/j.jhepr.2022.100448. View

17.

Kakiyama G, Pandak W, Gillevet P, Hylemon P, Heuman D, Daita K . Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol. 2013; 58(5):949-55. PMC: 3936319. DOI: 10.1016/j.jhep.2013.01.003. View

18.

Yamamoto K, Honda T, Inukai Y, Yokoyama S, Ito T, Imai N . Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver Disease. Microorganisms. 2024; 12(3). PMC: 10974311. DOI: 10.3390/microorganisms12030610. View

19.

Bajaj J, Ridlon J, Hylemon P, Thacker L, Heuman D, Smith S . Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol. 2011; 302(1):G168-75. PMC: 3345956. DOI: 10.1152/ajpgi.00190.2011. View

20.

Bert F, Valla D, Moreau R, Nicolas-Chanoine M . Viridans group streptococci causing spontaneous bacterial peritonitis and bacteremia in patients with end-stage liver disease. Liver Transpl. 2008; 14(5):710-1. DOI: 10.1002/lt.21474. View